Treatment of Mood Disorders with Antiepileptic Medications: Clinical and Theoretical Implications

Epilepsia

Volumn 24, Issue , 1983, Pages S97-S108

  Post, Robert M ^a   Uhde, Thomas W ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Antiepileptic medications; Carbamazepine; Depression; Electroconvulsive seizures; Mania; Mood disorders; Psychosis; Treatment

Indexed keywords

BENZODIAZEPINE; CARBAMAZEPINE; CLONAZEPAM; DIAZEPAM; PHENYTOIN; VALPROIC ACID;

AFFECTIVE NEUROSIS; BEHAVIOR DISORDER; CENTRAL NERVOUS SYSTEM; DEPRESSION; DRUG THERAPY; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; ORAL DRUG ADMINISTRATION; REVIEW; THERAPY;

ANTICONVULSANTS; BIPOLAR DISORDER; CARBAMAZEPINE; CLINICAL TRIALS; CLONAZEPAM; DEPRESSIVE DISORDER; DIAZEPAM; DOUBLE-BLIND METHOD; HUMAN; PHENYTOIN; VALPROIC ACID;

EID: 0021073332     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1983.tb04652.x     Document Type: Article

References (88)

1. Effects of carbamazepine, clonazepam, and phenytoin on seizure threshold in amygdala and cortex
2. Development of a new pharmacological seizure model: effects of anticonvulsants on cortical‐ and amygdala‐kindled seizures in the rat
3. The pharmacology of kindling
4. Blockade of tardive seizures in rats by electroconvulsive shock
5. Therapeutic effects of carbamazepine in affective illness: a preliminary report
6. Carbamazepine (Tegretol) in manic‐depressive illness: a new treatment
7. The GABA hypothesis of affective illness: influence of clinically effective antimanic drugs on GABA turnover
8. GABA and affective illness
9. Clinical pharmacokinetics of carbamazepine
10. The switch process from depression to mania: relationship to drugs which alter brain amines
11. Electrical convulsion therapy in the treatment of epilepsy
12. Acute anticonvulsant activity of structural analogues of valproic acid and changes in brain GABA and aspartate content
13. Antimanic effects of clonazepam
14. Antiepileptic and psychotropic effect of carbamazepine (Tegretol) in the treatment of psychomotor epilepsy
15. Behavioral effects of carbamazepine
16. Psychotropic effects of carbamazepine in epilepsy: a double‐blind comparison with phenytoin
17. An experimental model of temporal lobe epilepsy: studies on the convulsant properties of cocaine
18. Amygdala hyperspindling and seizures induced by cocaine
19. Effect of sodium valproate in mania. The GABA‐hypothesis of affective disorders
20. Anticonvulsant effect of carbamazepine. An attempt to distinguish between the potency of the parent drug and its epoxide metabolite
21. Bipolar illness after right hemispherectomy
22. Effectiveness of diphenylhydantoin in management of non‐epileptic psychomotor excitement states
23. Carbamazepine biotransformation
24. Role of inhibitory mechanisms in trigeminal neuralgia
25. The chemistry of carbamazepine
26. Carbamazepine in treatment cf violent schizophrenics
27. Evaluacion de la prueba de la lidocaina y del tratamiento con carbamazepine en pacientes con tinnitus
28. A lithium and carbamazepine combination in the treatment of bipolar disorder–a preliminary report
29. Valproate: mechanism of action
30. The diagnostic and therapeutic use of diphenylhydantoin in the subictal state and non‐epileptic dysphoria
31. Carbamazepine: mechanisms of action
32. Observations in electric shock therapy applied to problems of epilepsy
33. Attempts at treatment of schizophrenia and other non‐epileptic psychoses with dilantin
34. Carbamazepine and lithium carbonate in the treatment of refractory affective disorders
35. Carbamazepine (Tegretol) in the treatment of neuralgia: use and side effects
36. The use of dilantin on the treatment of psychotic patients unresponsive to other treatment
37. Le dipropylacetamide dans le traitement de la psy‐chose maniaco‐depressive
38. A study of the action of valproic acid on the kindling effect
39. Possible synergistic action between carbamazepine and lithium carbonate in the treatment of three acutely manic patients
40. Potential anticonvulsants: GABA receptor agonists
41. Carbamazepine for the violent psychiatric patient
42. Specific and potent interactions of carbamazepine with brain adenosine receptors
43. The treatment of tinnitus with oral anticonvulsants
44. Carbamazepine in the psychiatric patient
45. Carbamazepine, a possible adjunct to or alternative for lithium in bipolar disorder
46. Changes in seizure threshold following ECS and bicuculine‐induced convulsions
47. A preliminary double‐blind study of the efficacy of carbamazepine in prophylaxis of manic‐depressive illness
48. Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: a double‐blind controlled study
49. Anti‐manic and prophylactic effects of carbamazepine (Tegretol) on manic‐depressive psychosis fin Japanese]
50. Anti‐manic and prophylactic effects of carbamazepine on manic‐depressive psychosis
51. Psychotropic effect of antiepileptic drugs
52. Lidocaine‐kindled limbic seizures: behavioral implications
53. Slow and rapid onset of manic episodes: implications for underlying biology
54. Efficacy of carbamazepine in manic‐depressive illness: implications for underlying mechanisms
55. Electroconvulsive shock inhibits amygdala kindling [Abstract 187.13]
56. Carbamazepine as a treatment for depressive illness: lithium non‐responsive rapid cyclers
57. Biochemical effects of carbamazepine: possible mechanisms of action in affective and seizure disorders
58. Carbamazepine, temporal lobe epilepsy, and manic‐depressive illness
59. Carbamazepine and its ‐10,11‐epoxide metabolite in plasma and CSF: relationship to antidepressant response
60. Prophylactic efficacy of carbamazepine in manic‐depressive illness
61. Biochemical effects of carbamazepine: relationship to its mechanisms of action in affective illness
62. Psychiatric effects of the anticonvulsant regimens
63. Anticonvulsant and antidepressant properties of electroconvulsive therapy: a proposed mechanism of action
64. Management of tinnitus aurium with lidocaine and carbamazepine
65. The ‘march’ of symptoms in a psychotic decompensation: case report and theoretical implications
66. Behavioural effects of anti‐epileptic drugs
67. The use of carbamazepine (Tegretol) in the control of manic‐depressive psychosis and other manic, depressive states
68. L'effet d'embrasement (kindling effect) par stimulation amygadieune chez la chat et le rat: approche neurophysiologique et neuropharmacologique
69. Control of grand mal epilepsy with electro‐shock
70. Psychiatric implications of anticonvulsant drugs
71. Single‐dose kinetics and metabolism of carbamazepine‐10,11‐epoxide
72. Psychotropic effects of anticonvulsant drugs
73. The usefulness of diphenylhydantoin in treatment of non‐epileptic emotional disorder
74. Pharmacological prophylaxis in the kindling model of epilepsy
75. Prophylactic effects of phenytoin, phenobarbital, and carbamazepine examined in kindled cat preparations
76. Effects of lidocaine on spontaneous cortical and subcortical electrical activity
77. Rapid cycling in manic‐depressives induced by tricyclic antidepressants
78. Interactions of carbamazepine with benzodiazepine systems in amygdala kindling [Abstract 224.5]
79. Mechanisms of action of antiepileptic drugs
80. Electro‐convulsive therapy: a help for epileptics
81. Low cerebrospinal fluid gamma‐aminobutyric acid content in seizure patients
82. Carbamazepine: an alternative to lithium therapy